Current Challenges in the Development of Platelet‐Rich Plasma‐Based Therapies.

Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet‐rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new proces...

Descripción completa

Detalles Bibliográficos
Publicado en:	BioMed Research International Vol. 2024; pp. 1 - 22
Autores principales:	Mercader-Ruiz, Jon, Beitia, Maider, Delgado, Diego, Sánchez, Pello, Porras, Begoña, Gimeno, Irene, González, Sergio, Benito-Lopez, Fernando, Basabe-Desmonts, Lourdes, Sánchez, Mikel, Lacchini, Silvia
Formato:	pictorial review tables/charts Journal Article
Publicado:	Wiley-Blackwell 8/9/2024
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Sumario:	Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet‐rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP‐obtaining methods that attempt to modify the molecular composition of the plasma.